Erratum: Efficacy of the designer antimicrobial peptide SHAP1 in wound healing and wound infection (Amino Acids (2014) DOI 10.1007/s00726-014-1780-5);Efficacy of the designer antimicrobial peptide SHAP1 in wound healing and wound infection

Amino Acids

Volumn 46, Issue 10, 2014, Pages 2333-2343

  Jung Kim, Da ^a   Lee, Young Woong ^a   Park, Myung Keun ^a   Shin, Ju Ri ^a   Lim, Ki Jung ^a   Cho, Ju Hyun ^b   Kim, Sun Chang ^a  

^a Korea Advanced Institute of Science and Technology (KAIST)   (South Korea)

^b Gyeongsang National University   (South Korea)

Author keywords

Antimicrobial peptides; Cytotoxicity; Infected wound treatment; Protease resistance; SHAP1; Wound healing

Indexed keywords

ANTIMICROBIAL CATIONIC PEPTIDE; ANTIMICROBIAL PEPTIDE LL-37; CATHELICIDIN; SHAP1 PEPTIDE; TOPICAL ANTIINFECTIVE AGENT;

ANIMAL; BAGG ALBINO MOUSE; CELL LINE; CELL MOTION; CELL SURVIVAL; COMPARATIVE STUDY; CYTOLOGY; DRUG EFFECTS; DRUG STABILITY; ERYTHROCYTE; FEMALE; GROWTH, DEVELOPMENT AND AGING; HEMOLYSIS; HUMAN; KERATINOCYTE; MICROBIOLOGY; PROTEIN STABILITY; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; WOUND HEALING; WOUND INFECTION;

ANIMALS; ANTI-INFECTIVE AGENTS, LOCAL; ANTIMICROBIAL CATIONIC PEPTIDES; CATHELICIDINS; CELL LINE; CELL MOVEMENT; CELL SURVIVAL; DRUG STABILITY; ERYTHROCYTES; FEMALE; HEMOLYSIS; HUMANS; KERATINOCYTES; MICE, INBRED BALB C; PROTEIN STABILITY; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; WOUND HEALING; WOUND INFECTION;

EID: 84930741185     PISSN: 09394451     EISSN: 14382199     Source Type: Journal    
DOI: 10.1007/s00726-014-1804-1     Document Type: Erratum

References (47)

1. Andl CD, Mizushima T, Oyama K, Bowser M, Nakagawa H, Rustgi AK (2004) EGFR-induced cell migration is mediated predominantly by the JAK-STAT pathway in primary esophageal keratinocytes. Am J Physiol Gastrointest Liver Physiol 287:G1227-G1237
2. Baroni A, Donnarumma G, Paoletti I, Longanesi-Cattani I, Bifulco K, Tufano MA, Carriero MV (2009) Antimicrobial human beta-defensin-2 stimulates migration, proliferation and tube formation of human umbilical vein endothelial cells. Peptides 30:267-272
3. Bowler PG (2002) Wound pathophysiology, infection and therapeutic options. Ann Med 34:419-427
4. Carretero M, Del Rio M, Garcia M, Escamez MJ, Mirones I, Rivas L, Balague C, Jorcano JL, Larcher F (2004) A cutaneous gene therapy approach to treat infection through keratinocyte-targeted overexpression of antimicrobial peptides. FASEB J 18:1931-1933
5. Carretero M, Escamez MJ, Garcia M, Duarte B, Holguin A, Retamosa L, Jorcano JL, Rio MD, Larcher F (2008) In vitro and in vivo wound healing-promoting activities of human cathelicidin LL-37. J Invest Dermatol 128:223-236
6. Chiller K, Selkin BA, Murakawa GJ (2001) Skin microflora and bacterial infections of the skin. J Investig Dermatol Symp Proc 6:170-174
7. Choi JH, Choi DK, Sohn KC, Kwak SS, Suk J, Lim JS, Shin I, Kim SW, Lee JH, Joe CO (2012) Absence of a human DnaJ protein hTid-1S correlates with aberrant actin cytoskeleton organization in lesional psoriatic skin. J Biol Chem 287:25954-25963
8. De Zotti M, Biondi B, Park Y, Hahm KS, Crisma M, Toniolo C, Formaggio F (2012) Antimicrobial lipopeptaibol trichogin GA IV: role of the three Aib residues on conformation and bioactivity. Amino Acids 43:1761-1777
9. Gopinath D, Kumar MS, Selvaraj D, Jayakumar R (2005) Pexiganan-incorporated collagen matrices for infected wound-healing processes in rat. J Biomed Mater Res A 73:320-331
10. Gronberg A, Zettergren L, Agren MS (2011) Stability of the cathelicidin peptide LL-37 in a non-healing wound environment. Acta Derm Venereol 91:511-515
11. Guay DR (2003) Treatment of bacterial skin and skin structure infections. Expert Opin Pharmacother 4:1259-1275
12. Hancock RE, Sahl HG (2006) Antimicrobial and host-defense peptides as new anti-infective therapeutic strategies. Nat Biotechnol 24:1551-1557
13. Hawrani A, Howe RA, Walsh TR, Dempsey CE (2008) Origin of low mammalian cell toxicity in a class of highly active antimicrobial amphipathic helical peptides. J Biol Chem 283:18636-18645
14. Jacobsen F, Mittler D, Hirsch T, Gerhards A, Lehnhardt M, Voss B, Steinau HU, Steinstraesser L (2005) Transient cutaneous adenoviral gene therapy with human host defense peptide hCAP-18/LL-37 is effective for the treatment of burn wound infections. Gene Ther 12:1494-1502
15. Jang SA, Kim H, Lee JY, Shin JR, da Kim J, Cho JH, Kim SC (2012) Mechanism of action and specificity of antimicrobial peptides designed based on buforin IIb. Peptides 34:283-289
16. Kim SC, Park IY, Kim JM (2008) Salt-resistant antimicrobial peptides and antimicrobial composition comprising thereof. Korea Patent 10-0836596
17. Kim H, Jang JH, Kim SC, Cho JH (2013) De novo generation of short antimicrobial peptides with enhanced stability and cell specificity. J Antimicrob Chemother. doi: 10.1093/jac/dkt322
18. Koczulla R, von Degenfeld G, Kupatt C, Krotz F, Zahler S, Gloe T, Issbrucker K, Unterberger P, Zaiou M, Lebherz C, Karl A, Raake P, Pfosser A, Boekstegers P, Welsch U, Hiemstra PS, Vogelmeier C, Gallo RL, Clauss M, Bals R (2003) An angiogenic role for the human peptide antibiotic LL-37/hCAP-18. J Clin Invest 111:1665-1672
19. Lee PH, Rudisill JA, Lin KH, Zhang L, Harris SM, Falla TJ, Gallo RL (2004) HB-107, a nonbacteriostatic fragment of the antimicrobial peptide cecropin B, accelerates murine wound repair. Wound Repair Regen 12:351-358
20. Lipsky BA, Hoey C (2009) Topical antimicrobial therapy for treating chronic wounds. Clin Infect Dis 49:1541-1549
21. Ma QQ, Dong N, Shan AS, Lv YF, Li YZ, Chen ZH, Cheng BJ, Li ZY (2012) Biochemical property and membrane-peptide interactions of de novo antimicrobial peptides designed by helix-forming units. Amino Acids 43:2527-2536
22. Malmsten M, Kasetty G, Pasupuleti M, Alenfall J, Schmidtchen A (2011) Highly selective end-tagged antimicrobial peptides derived from PRELP. PLoS One 6:e16400
23. Marr AK, Gooderham WJ, Hancock RE (2006) Antibacterial peptides for therapeutic use: obstacles and realistic outlook. Curr Opin Pharmacol 6:468-472
24. McHugh SM, Collins CJ, Corrigan MA, Hill AD, Humphreys H (2011) The role of topical antibiotics used as prophylaxis in surgical site infection prevention. J Antimicrob Chemother 66:693-701
25. Mookherjee N, Hancock RE (2007) Cationic host defence peptides: innate immune regulatory peptides as a novel approach for treating infections. Cell Mol Life Sci 64:922-933
26. Mookherjee N, Brown KL, Bowdish DM, Doria S, Falsafi R, Hokamp K, Roche FM, Mu R, Doho GH, Pistolic J, Powers JP, Bryan J, Brinkman FS, Hancock RE (2006) Modulation of the TLR-mediated inflammatory response by the endogenous human host defense peptide LL-37. J Immunol 176:2455-2464
27. Myhrman E, Hakansson J, Lindgren K, Bjorn C, Sjostrand V, Mahlapuu M (2012) The novel antimicrobial peptide PXL150 in the local treatment of skin and soft tissue infections. Appl Microbiol Biotechnol 97:3085-3096
28. Niyonsaba F, Ushio H, Nakano N, Ng W, Sayama K, Hashimoto K, Nagaoka I, Okumura K, Ogawa H (2007) Antimicrobial peptides human beta-defensins stimulate epidermal keratinocyte migration, proliferation and production of proinflammatory cytokines and chemokines. J Investig Dermatol 127:594-604
29. Oda K, Matsuoka Y, Funahashi A, Kitano H (2005) A comprehensive pathway map of epidermal growth factor receptor signaling. Mol Syst Biol 1(2005):0010
30. Overhage J, Campisano A, Bains M, Torfs EC, Rehm BH, Hancock RE (2008) Human host defense peptide LL-37 prevents bacterial biofilm formation. Infect Immun 76:4176-4182
31. Park IY, Cho JH, Kim KS, Kim YB, Kim MS, Kim SC (2004) Helix stability confers salt resistance upon helical antimicrobial peptides. J Biol Chem 279:13896-13901
32. Pasupuleti M, Schmidtchen A, Chalupka A, Ringstad L, Malmsten M (2009) End-tagging of ultra-short antimicrobial peptides by W/F stretches to facilitate bacterial killing. PLoS One 4:e5285
33. Philp D, Badamchian M, Scheremeta B, Nguyen M, Goldstein AL, Kleinman HK (2003) Thymosin beta 4 and a synthetic peptide containing its actin-binding domain promote dermal wound repair in db/db diabetic mice and in aged mice. Wound Repair Regen 11:19-24
34. Puddicombe SM, Polosa R, Richter A, Krishna MT, Howarth PH, Holgate ST, Davies DE (2000) Involvement of the epidermal growth factor receptor in epithelial repair in asthma. FASEB J 14:1362-1374
35. Radek KA, Taylor KR, Gallo RL (2009) FGF-10 and specific structural elements of dermatan sulfate size and sulfation promote maximal keratinocyte migration and cellular proliferation. Wound Repair Regen 17:118-126
36. Rawlings ND, Barrett AJ, Bateman A (2010) MEROPS: the peptidase database. Nucleic Acids Res 38((Database issue)):D227-D233
37. Shaykhiev R, Beisswenger C, Kandler K, Senske J, Puchner A, Damm T, Behr J, Bals R (2005) Human endogenous antibiotic LL-37 stimulates airway epithelial cell proliferation and wound closure. Am J Physiol Lung Cell Mol Physiol 289:L842-L848
38. Shin YP, Park HJ, Shin SH, Lee YS, Park S, Jo S, Lee YH, Lee IH (2010) Antimicrobial activity of a halocidin-derived peptide resistant to attacks by proteases. Antimicrob Agents Chemother 54:2855-2866
39. Shin JR, Lim KJ, da Kim J, Cho JH, Kim SC (2013) Display of multimeric antimicrobial peptides on the Escherichia coli cell surface and its application as whole-cell antibiotics. PLoS One 8:e58997
40. Sieprawska-Lupa M, Mydel P, Krawczyk K, Wojcik K, Puklo M, Lupa B, Suder P, Silberring J, Reed M, Pohl J, Shafer W, McAleese F, Foster T, Travis J, Potempa J (2004) Degradation of human antimicrobial peptide LL-37 by Staphylococcus aureus-derived proteinases. Antimicrob Agents Chemother 48:4673-4679
41. Steinstraesser L, Koehler T, Jacobsen F, Daigeler A, Goertz O, Langer S, Kesting M, Steinau H, Eriksson E, Hirsch T (2008) Host defense peptides in wound healing. Mol Med 14:528-537
42. Steinstraesser L, Kraneburg UM, Hirsch T, Kesting M, Steinau HU, Jacobsen F, Al-Benna S (2009) Host defense peptides as effector molecules of the innate immune response: a sledgehammer for drug resistance? Int J Mol Sci 10:3951-3970
43. Stromstedt AA, Pasupuleti M, Schmidtchen A, Malmsten M (2009) Evaluation of strategies for improving proteolytic resistance of antimicrobial peptides by using variants of EFK17, an internal segment of LL-37. Antimicrob Agents Chemother 53:593-602
44. Tokumaru S, Sayama K, Shirakata Y, Komatsuzawa H, Ouhara K, Hanakawa Y, Yahata Y, Dai X, Tohyama M, Nagai H, Yang L, Higashiyama S, Yoshimura A, Sugai M, Hashimoto K (2005) Induction of keratinocyte migration via transactivation of the epidermal growth factor receptor by the antimicrobial peptide LL-37. J Immunol 175:4662-4668
45. Torpy JM, Burke A, Glass RM (2005) JAMA patient page. Wound infections. JAMA 294:2122
46. Winter J, Wenghoefer M (2012) Human defensins: potential tools for clinical applications. Polymers 4:691-709
47. Yin J, Yu FS (2010) LL-37 via EGFR transactivation to promote high glucose-attenuated epithelial wound healing in organ-cultured corneas. Invest Ophthalmol Vis Sci 51:1891-1897